1. Home
  2. CHRO vs PAPL Comparison

CHRO vs PAPL Comparison

Compare CHRO & PAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • PAPL
  • Stock Information
  • Founded
  • CHRO 2002
  • PAPL 2015
  • Country
  • CHRO United States
  • PAPL Canada
  • Employees
  • CHRO N/A
  • PAPL N/A
  • Industry
  • CHRO
  • PAPL Finance: Consumer Services
  • Sector
  • CHRO
  • PAPL Finance
  • Exchange
  • CHRO Nasdaq
  • PAPL Nasdaq
  • Market Cap
  • CHRO 3.8M
  • PAPL 3.9M
  • IPO Year
  • CHRO 2024
  • PAPL 2023
  • Fundamental
  • Price
  • CHRO $1.90
  • PAPL $0.45
  • Analyst Decision
  • CHRO Strong Buy
  • PAPL Strong Buy
  • Analyst Count
  • CHRO 1
  • PAPL 2
  • Target Price
  • CHRO N/A
  • PAPL $5.25
  • AVG Volume (30 Days)
  • CHRO 855.2K
  • PAPL 132.5K
  • Earning Date
  • CHRO 02-20-2025
  • PAPL 01-31-2025
  • Dividend Yield
  • CHRO N/A
  • PAPL N/A
  • EPS Growth
  • CHRO N/A
  • PAPL N/A
  • EPS
  • CHRO N/A
  • PAPL N/A
  • Revenue
  • CHRO N/A
  • PAPL $2,688,987.00
  • Revenue This Year
  • CHRO N/A
  • PAPL $22.61
  • Revenue Next Year
  • CHRO N/A
  • PAPL $30.00
  • P/E Ratio
  • CHRO N/A
  • PAPL N/A
  • Revenue Growth
  • CHRO N/A
  • PAPL 7.46
  • 52 Week Low
  • CHRO $0.45
  • PAPL $0.41
  • 52 Week High
  • CHRO $6.00
  • PAPL $2.14
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 86.63
  • PAPL 44.70
  • Support Level
  • CHRO $0.81
  • PAPL $0.43
  • Resistance Level
  • CHRO $1.10
  • PAPL $0.48
  • Average True Range (ATR)
  • CHRO 0.26
  • PAPL 0.05
  • MACD
  • CHRO 0.08
  • PAPL -0.00
  • Stochastic Oscillator
  • CHRO 70.64
  • PAPL 19.38

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

About PAPL Pineapple Financial Inc.

Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.

Share on Social Networks: